Dr. Joseph Kozikowski to serve in Medical Director role for an emerging leader in wound care.
FRAMINGHAM, MA – June 12, 2003 – Clinivation, Inc. announced today that clinivation Founder and CEO Joseph Kozikowski, M.D. has been appointed Medical Director of Ogenix, Inc., an emerging leader in wound care, with headquarters in Cleveland, Ohio.
In this role, Dr. Kozikowski will lead and support certain medical, product development, regulatory, and business development initiatives for Ogenix’s transdermal sustained-delivery oxygen therapy product line.
Quotes & Commentary:
“It is an honor and my pleasure to serve Ogenix in this important role, and I thank Ogenix Chief Executive Mel Burk and the Ogenix Board of Directors for their vision and support,” said clinivation Founder and CEO Joseph Kozikowski, M.D.
About Ogenix:
Ogenix, Inc. (Cleveland, OH) is a medical device company dedicated to developing, manufacturing, and marketing innovative, miniature oxygen generators for wound care and other important medical and surgical applications.
Ogenix’s lead product- EpiFLO SDTM- has received FDA approval for the treatment of diabetic foot ulcers, venous leg ulcers, pressure ulcers, and other important medical and surgical indications.
